Cell-free Expression, Purification and Immunoreactivity Assessment of Recombinant Fasciola Hepatica Saposin-like Protein-2

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2018 Jul 23

PMID 30032380

Citations 2

Authors

Marcos J Ramos-Benitez

Luis M Lopez-Cruz

Vasti Aguayo

Caleb Ruiz-Jimenez

Ana M Espino

Affiliations

Soon will be listed here.

Abstract

Cell free protein synthesis has become a powerful method for the high-throughput production of proteins that are difficult to express in living cells. The protein SAP2 of Fasciola hepatica (FhSAP2), which has demonstrated to be both, an excellent vaccine candidate against experimental fascioliasis and a good antigen for serodiagnosis of human chronic fascioliasis, is a typical example of a molecule that is difficult to produce. This is mainly due to its tendency to get over-expressed in inclusion bodies by prokaryotes. FhSAP2 expressed in an Escherichia coli-based expression system is poorly glycosylated, insoluble and often undergoes improper folding leading it to reduced immunogenicity. In this work, FhSAP2 was expressed in vitro using the eukaryote cell free system, TNT T7 Quick coupled transcription/translation, that has been designed for the expression of PCR-generated DNA templates. FhSAP2 was expressed in micro-volumes and purified by an affinity chromatography method, which gave a protein yield of 500 µg/ml as determined by bicinchoninic acid assay method. Circular dichroism, Western blotting and enzyme-linked immunosorbent assay analysis were used to confirm the secondary structure, purity and integrity of protein. Results demonstrate that FhSAP2 can be expressed in a cell-free system retaining its main conformational and antigenic properties. The protein purified could be used in immunization experiments and immunodiagnostic techniques.

Citing Articles

Strategies for Optimizing the Production of Proteins and Peptides with Multiple Disulfide Bonds.

Ma Y, Lee C, Park J Antibiotics (Basel). 2020; 9(9).

PMID: 32858882 PMC: 7558204. DOI: 10.3390/antibiotics9090541.

Cell-Free Protein Synthesis: A Promising Option for Future Drug Development.

Dondapati S, Stech M, Zemella A, Kubick S BioDrugs. 2020; 34(3):327-348.

PMID: 32198631 PMC: 7211207. DOI: 10.1007/s40259-020-00417-y.

References

Espino A, Morales A, Delgado B, Rivera F, Figueroa O, Suarez E . Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct. Ethn Dis. 2010; 20(1 Suppl 1):S1-17-23. PMC: 3260556. View

Solano-Parada J, Gonzalez-Gonzalez G, Torro L, dos Santos M, Espino A, Burgos M . Effectiveness of intranasal vaccination against Angiostrongylus costaricensis using a serine/threonine phosphatase 2 A synthetic peptide and recombinant antigens. Vaccine. 2010; 28(32):5185-96. DOI: 10.1016/j.vaccine.2010.05.072. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Figueroa-Santiago O, Delgado B, Espino A . Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis. Diagn Microbiol Infect Dis. 2011; 70(3):355-61. PMC: 3260655. DOI: 10.1016/j.diagmicrobio.2011.03.016. View

Caban-Hernandez K, Gaudier J, Ruiz-Jimenez C, Espino A . Development of two antibody detection enzyme-linked immunosorbent assays for serodiagnosis of human chronic fascioliasis. J Clin Microbiol. 2013; 52(3):766-72. PMC: 3957751. DOI: 10.1128/JCM.02875-13. View

Spirin A . High-throughput cell-free systems for synthesis of functionally active proteins. Trends Biotechnol. 2004; 22(10):538-45. DOI: 10.1016/j.tibtech.2004.08.012. View

Landis J, Koch G . An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977; 33(2):363-74. View

Espino A, Hillyer G . Molecular cloning of a member of the Fasciola hepatica saposin-like protein family. J Parasitol. 2003; 89(3):545-52. DOI: 10.1645/GE-3113. View

Shin S, Hsu A, Chastain H, Cruz L, Elder E, Sapp S . Development of Two FhSAP2 Recombinant-Based Assays for Immunodiagnosis of Human Chronic Fascioliasis. Am J Trop Med Hyg. 2016; 95(4):852-855. PMC: 5062787. DOI: 10.4269/ajtmh.16-0253. View

10.

Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M . Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150(1):76-85. DOI: 10.1016/0003-2697(85)90442-7. View

11.

Espino A, Hillyer G . A novel Fasciola hepatica saposinlike recombinant protein with immunoprophylactic potential. J Parasitol. 2004; 90(4):876-9. DOI: 10.1645/GE-215R. View

12.

Espino A, Rivera F . Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis. Vet Parasitol. 2010; 169(1-2):82-92. PMC: 3260557. DOI: 10.1016/j.vetpar.2009.12.018. View

13.

Nakane P, Kawaoi A . Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem. 1974; 22(12):1084-91. DOI: 10.1177/22.12.1084. View

14.

Caban-Hernandez K, Espino A . Differential expression and localization of saposin-like protein 2 of Fasciola hepatica. Acta Trop. 2013; 128(3):591-7. PMC: 3837425. DOI: 10.1016/j.actatropica.2013.08.012. View

15.

Reed M, Strugnell R, Panaccio M, Spithill T . A novel member of the NK-lysin protein family is developmentally regulated and secreted by Fasciola hepatica. Mol Biochem Parasitol. 2000; 105(2):297-303. DOI: 10.1016/s0166-6851(99)00185-1. View

16.

Wedrychowicz H, Kesik M, Kaliniak M, Kozak-Cieszczyk M, Jedlina-Panasiuk L, Jaros S . Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke. Vet Parasitol. 2007; 147(1-2):77-88. DOI: 10.1016/j.vetpar.2007.03.023. View

17.

Kesik M, Jedlina-Panasiuk L, Kozak-Cieszczyk M, Plucienniczak A, Wedrychowicz H . Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1). Vaccine. 2007; 25(18):3619-28. DOI: 10.1016/j.vaccine.2007.01.057. View

18.

Swartz J . Developing cell-free biology for industrial applications. J Ind Microbiol Biotechnol. 2006; 33(7):476-85. DOI: 10.1007/s10295-006-0127-y. View

19.

Espino A, Dumenigo B, Fernandez R, Finlay C . Immunodiagnosis of human fascioliasis by enzyme-linked immunosorbent assay using excretory-secretory products. Am J Trop Med Hyg. 1987; 37(3):605-8. DOI: 10.4269/ajtmh.1987.37.605. View

20.

Grams R, Adisakwattana P, Ritthisunthorn N, Eursitthichai V, Vichasri-Grams S, Viyanant V . The saposin-like proteins 1, 2, and 3 of Fasciola gigantica. Mol Biochem Parasitol. 2006; 148(2):133-43. DOI: 10.1016/j.molbiopara.2006.03.007. View